Regeneron to Acquire 23andme, Vows Ethical DNA Data Use
Regeneron Pharmaceuticals wants to buy the bankrupt gene testing company 23andme - and promises to prioritize ethical use of the 15 million customers' DNA data, writes Reuters.
SwedenRegeneron Pharmaceuticals wants to buy the bankrupt gene testing company 23andme - and promises to prioritize ethical use of the 15 million customers' DNA data, writes Reuters.
SwedenYou're up to date in William Pickering
That's every story in William Pickering for now.